Fig. 2.
Chemotherapy regimens prescribed during the study period (for guideline adherence evaluation; study period November 2019–July 2022). Gem gemcitabine, mono monotherapy
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.